ARTICLE | Clinical News
GeoVax Labs preclinical data
September 21, 2015 7:00 AM UTC
In guinea pigs and hamsters, GOVX-E301 conferred 100% protection against Ebola virus infection. GeoVax said it is planning a challenge study in non-human primates of the recombinant modified vaccinia ...